ResMed Inc. (NYSE:RMD) is set to announce first quarter earning results on Thursday 29th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, RMD to report 1Q21 income of $ 1.03 per share.
For the full year, analysts anticipate top line of $ 3096.12 million, while looking forward to income of $ 4.81 per share bottom line.
Previous Quarter Performance
ResMed Inc. unwinded income for the fourth quarter of $ 1.33 per share, from the revenue of $ 770.34 million. The consensus estimates are income of $ 1.08 per share from $ 746.90 million in revenue. The bottom line results beat street analysts by $ 0.25 or 23.15 percent, at the same time, top line results outshined analysts by $ 23.44 million or 3.14 percent.
Stock Performance
Shares of ResMed Inc. traded low $ -4.29 or -2.32 percent on Wednesday, reaching $ 180.56 with volume of 612.30 thousand shares. ResMed Inc. has traded high as $ 182.92 and has cracked $ 180.37 on the downward trend
According to the previous trading day, closing price of $ 180.56, representing a 69.82 % increase from the 52 week low of $ 108.85 and a 11.56 % decrease over the 52 week high of $ 209.00.
The company has a market capital of $ 26.16 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
ResMed Inc. will be hosting a conference call at 4:30 PM eastern time on 29th October 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.resmed.com
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
